Radioactive iodine in the treatment of medullary thyroid carcinoma: A controlled multicenter study

European Journal of Endocrinology

Volumn 168, Issue 5, 2013, Pages 779-786

  Meijer, J A A ^a   Bakker, L E H ^b   Valk, G D ^c   De Herder, W W ^d   De Wilt, J H W ^e   Netea Maier, R T ^e   Schaper, N ^f   Fliers, E ^g   Lips, P ^h   Plukker, J T ⁱ   Links, T P ⁱ   Smit, J A ^e  

^a ALBERT SCHWEITZER HOSPITAL   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^g UNIVERSITY OF AMSTERDAM   (Netherlands)

^h VU UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SPECIFIC SURVIVAL; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIOISOTOPE THERAPY; RETROSPECTIVE STUDY; SCHOOL CHILD; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY; TUMOR LOCALIZATION;

AGED; CARCINOMA, MEDULLARY; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NETHERLANDS; PROGNOSIS; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 84877116666     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-12-0943     Document Type: Article

References (31)

1. Dralle H, Damm I, Scheumann G.F., Kotzerke J., Kupsch E, Geerlings H & Pichlmayr R. Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma. Surgery Today 1994 24 112-121. (doi:10.1007/BF02473391)
2. Moley JF & DeBenedetti MK. Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection. Annals of Surgery 1999 229 880-887. (doi:10.1097/00000658-199906000-00016)
3. Ukkat J, Gimm O, Brauckhoff M., Bilkenroth U & Dralle H. Single center experience in primary surgery for medullary thyroid carcinoma. World Journal of Surgery 2004 28 1271-1274. (doi:10.1007/s00268-004-7608-9)
4. Kloos RT, Eng C, Evans D.B., Francis GL, Gagel RF, Gharib H, Moley J.F., Pacini F., Ringel MD, Schlumberger M et al. Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 2009 19 565-612. (doi:10.1089/thy. 2008.0403)
5. Cupisti K, Wolf A, Raffel A., Schott M, Miersch D, Yang Q., Eisenberger CF, Röher HD & Knoefel WT. Long-term clinical and biochemical follow-up in medullary thyroid carcinoma: a single institution's experience over 20 years. Annals of Surgery 2007 246 815-821. (doi:10.1097/SLA.0b013e31813e66b9)
6. Dottorini ME, Assi A, Sironi M., Sangalli G, Spreafico G & Colombo L. Multivariate analysis of patients with medullary thyroid carcinoma. Cancer 1996 77 1556-1565. (doi:10.1002/(SICI)1097-0142(19960415)77:8< 1556::AID-CNCR20O3.0.CO;2-Y)
7. Raue F, Kotzerke J, Reinwein D., Schröder S, Röher HD, Deckart H, Höfer R, Ritter M, Seif F, Buhr H et al. Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German Medullary Thyroid Carcinoma Register. Clinical Investigator 1993 71 7-12. (doi:10.1007/ BF00210956)
8. Bergholm U, Adami HO, Bergstrom R, Backdahl M & Akerstrom G. Long-term survival in sporadic and familial medullary thyroid carcinoma with special reference to clinical characteristics as prognostic factors. Acta Chirurgica Scandinavica 1990 156 37-46.
9. Barbet J, Campion L, Kraeber-Bodere F & Chatal JF. Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 2005 90 6077-6084. (doi:10.1210/jc.2005-0044)
10. Gawlik T, d'Amico A, Szpak-Ulczok S, Skoczylas A., Gubała E, Chorazy A, Gorczewski K. Włoch J & Jarzab B. The prognostic value of tumor markers doubling times in medullary thyroid carcinoma - preliminary report. Thyroid Research 2010 3 10. (doi:10.1186/1756-6614-3-10)
11. Miyauchi A. Evaluation of surgical results and prediction of prognosis by analysis of serum tumor marker levels: proposal of a theory tested on patients with medullary thyroid carcinoma. Japan Journal of Cancer Clinics 1988 34 739-743.
12. Meijer JA, le Cessie S, van den Hout WB, Kievit J, Schoones JW, Romijn JA & Smit JW. Calcitonin and carcinoembryonic antigen doubling times as prognostic factors in medullary thyroid carcinoma: a structured meta-analysis. Clinical Endocrinology 2010 72 534-542. (doi:10.1111/j.1365-2265.2009.03666.x)
13. Saad MF, Ordonez NG, Rashid R.K., Guido JJ, Hill CS Jr, Hickey RC & Samaan NA. Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patient. Medicine 1984 63 319-342. (doi:10.1097/00005792-198411 000-00001)
14. Nieuwenhuijzen Kruseman A.C., Bussemaker JK & Frolich M. Radioiodine in the treatment of hereditary medullary carcinoma of the thyroid. Journal of Clinical Endocrinology and Metabolism 1984 59 491-494. (doi:10.1210/jcem-59-3- 491)
15. Davis PW. A review of 17 cases of medullary carcinoma of the thyroid gland. Proceedings of the Royal Society of Medicine 1967 60 743-744.
16. Faik EM, Gursoy A, Erdogan G & Kamel N. Radioactive iodine treatment in medullary thyroid carcinoma. Nuclear Medicine Communications 2006 27 359-362. (doi:10.1097/01.mnm. 0000202860.30274.e4)
17. Bayraktar M, Gedik O, Akalin S., Usman A, Adalar N & Telatar F. The effect of radioactive iodine treatment on thyroid C cells. Clinical Endocrinology 1990 33 625-630. (doi:10.1111/j.1365-2265.1990.tb03901.x)
18. Lowery WD, Thomas CG Jr, Awbrey BJ, Rosenstein BD & Talmage RV. The late effect of subtotal thyroidectomy and radioactive iodine therapy on calcitonin secretion and bone mineral density in women treated for Graves' disease. Surgery 1986 100 1142-1149.
19. Ott RA, Hofmann C, Oslapas R., Nayyar R & Paloyan E. Radioiodine sensitivity of parafollicular C cells in aged Long-Evans rats. Surgery 1987 102 1043-1048.
20. Feinstein RE, Gimeno EJ, el Salhy M, Wilander E & Walinder G. Evidence of C-cell destruction in the thyroid gland of mice exposed to high 131I doses. Acta Radiologica. Oncology 1986 25 199-202. (doi:10.3109/ 02841868609136405)
21. Michael BE, Forouhar FA & Spencer RP. Medullary thyroid carcinomawith radioiodide transport. Clinical Nuclear Medicine 1985 10 274-279. (doi:10.1097/00003072-198504000-00010)
22. Shah KH, Oslapas R, Calandra D.B., Prinz RA, Ernst K, Hofmann C, Smith M., Chejfec G, Lawrence AM & Paloyan E. Effects of radiation on parafollicular C cells of the thyroid gland. Surgery 1983 94 989-994.
23. Deftos LJ & Stein MF. Radioiodine as an adjunct to the surgical treatment of medullary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 1980 50 967-968. (doi:10.1210/ jcem-50-5-967)
24. Hellman DE, Kartchner M, Van Antwerp JD, Salmon SE, Patton DD & O'Mara R. Journal of Clinical Endocrinology and Metabolism 1979 48 451-455. (doi:10.1210/ jcem-48-3-451)
25. Engelbach M, Gorges R, Forst T., Pfützner A, Dawood R., Heerdt S, Kunt T, Bockisch A & Beyer J. Improved diagnostic methods in the follow-up of medullary thyroid carcinoma by highly specific calcitonin measurements. Journal of Clinical Endocrinology and Metabolism 2000 85 1890-1894. (doi:10.1210/ jc.85.5.1890)
26. Twisk JWR. Multiple regressie-analyse: associatiemodellen en predictiemodellen. Inleiding in de toegepaste biostatistiek. In Inleiding in de toegepaste biostatistiek, edn 1, pp 229-273. Ed JWR Twisk. Amsterdam: Reed business, 2007.
27. Abraham DT, Low TH, Messina M, Jackson N., Gill A, Chou AS, Delbridge L, Learoyd D., Robinson BG, Sidhu S et al. Medullary thyroid carcinoma: long-term outcomes of surgical treatment. Annals of Surgical Oncology 2011 18 219-225. (doi:10.1245/ s10434-010-1339-y)
28. Ito Y, Miyauchi A, Yabuta T., Fukushima M, Inoue H, Tomoda C., Uruno T, Kihara M, Higashiyama T, Takamura Y et al. Alternative surgical strategies and favorable outcomes in patients with medullary thyroid carcinoma in Japan: experience of a single institution. World Journal of Surgery 2009 33 58-66. (doi:10.1007/s00268-008-9795-2)
29. Rendl G, Manzl M, Hitzl W., Sungler P & Pirich C. Long-term prognosis of medullary thyroid carcinoma. Clinical Endocrinology 2008 69 497-505. (doi:10.1111/j.1365-2265.2008.03229.x)
30. Machens A, Hofmann C, Hauptmann S & Dralle H. Locoregional recurrence and death from medullary thyroid carcinoma in a contemporaneous series: 5-year results. European Journal of Endocrinology 2007 157 85-93. (doi:10.1530/EJE-07- 0095)
31. Leggett MD, Chen SL, Schneider PD & Martinez SR. Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma. Annals of Surgical Oncology 2008 15 2493-2499. (doi:10.1245/s10434-008-0022-z)